As most long-ish term followers of mine know, I'm generally bearish on AI-driven drug discovery, but the approach detailed in this paper + Derek's commentary is actually what I believe to be the correct approach to utilizing AI in tx development /1https://blogs.sciencemag.org/pipeline/archives/2020/02/20/machine-learning-for-antibiotics …
-
Show this thread
Replying to @shaklakhani
The right way to do ML for drug discovery is by generating your own training datasets. Yes, that means you can't be a pure software company, and you need wet-lab amounts of capital!
9:42 AM - 24 Feb 2020
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.